InVivo now offers recombinant antigens for Corona virus / COVID-19 in vitro diagnostics.
Using transient gene expression in HEK cells, InVivo successfully produces different surface glycoprotein (S) variants. These include the SARS-CoV-2 Receptor Binding Domain (RBD) with C-terminal His-Tag, the S1 subdomain and the S2 subdomain with cleavable C-terminal His-Tag, and a soluble Spike protein. The proteins can be used for serological detection of COVID-19 antibodies in immunoassays, such as ELISA and Lateral Flow tests.
Further developments include stable CHO cell pools for larger quantities of antigens, as well as stable monoclonal CHO cell lines.
For detailed information about availabilities and pricing, please go to SARS-CoV-2 Antigens.
Picture credit Stock.adobe.com: Gilang Prihardono